Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles

GettyImages-155351397

How Do You Stay Confident in a Market Crash?

Time is a great teacher.


Doctor Blight

This Game Could Make Your Kids Rich One Day

All my crypto holdings are underwater, except for one -- the coolest game on the blockchain.


GettyImages-1251892822

3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

Our roundtable found three biotechs with a nice cash cushion.


GettyImages-1343150662

This Stock Is No. 1 on My Buy List

Digging into Appian's recent earnings report, I saw some amazing reasons to buy shares in 2022.


GettyImages-949947128

My Favorite Biotech

Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.

GettyImages-450806655

10 Amazing Stocks Under $10

This bear market has crushed the stocks of some incredible early-stage companies. Here are 10 stocks that the market used to love and are now trading in the single digits.


GettyImages-108224060

10 Amazing Stocks Under $10 (Part II)

Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here's a mini-portfolio of innovative companies trading under $10 a share right now.


GettyImages-1278530606

3 Small-Caps That Might Be Acquisition Candidates

Here's why our roundtable thinks OptimizeRx, Affimed and Blueprint Medicines are all buys right now.


GettyImages-506712124

3 Healthcare Companies With Revenue Spiking 100% or More

Here's why three Fool.com contributors are bullish on Outset Medical, Aurinia Pharmaceuticals, and Shockwave Medical.


GettyImages-800433994

4 Stocks That Could Turn $10,000 Into $200,000 by 2040

If you have a long investing time horizon, these strong performers could deliver massive gains.

GettyImages-1308866287

The Risk/Reward for Opendoor Stock Is Amazing

While Opendoor might fail spectacularly in the iBuyer marketplace, the upside is so massive that a small investment in this small-cap makes sense.


GettyImages-1296010642

The FDA Will Soon Give These 3 Healthcare Companies the Green Light

These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.


GettyImages-618179988

This Tiny Medical Device Will Make Billions of Dollars

Inspire Medical Systems is radically transforming how we treat sleep apnea.


GettyImages-501432924

The Safest Healthcare Stocks in the World

Stryker, Johnson & Johnson, and Intuitive Surgical can be counted on to be steady performers in your portfolio.


GettyImages-200398520-001

3 Risky Stocks With Huge Potential Upside

Why risk-tolerant investors want to own Shopify, Silvergate Capital, and Pieris Pharmaceuticals.

GettyImages-635978124

These COVID Stocks Will Be Incredibly Profitable

As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?


GettyImages-1284106261

3 Pharmaceutical Stocks With Awesome Futures

The market is so pessimistic about anything COVID-related that everything has gotten super cheap.


GettyImages-1200701272

It's Time to Be Bullish on COVID Stocks Again

Investors need to start thinking outside of the box.


GettyImages-1311139935

This Cheap Stock Is Making Billions in Biotech

With FDA authorization likely on the horizon, Novavax is positioned for even greater success.


GettyImages-1323184246

These Ridiculously Cheap Stocks Are Obvious Winners

The market has put these stocks on sale.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.